よむ、つかう、まなぶ。
資料３－２ －① 鈴木先生提出資料 (124 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00348.html |
| 出典情報 | 新型コロナウイルス感染症対策アドバイザリーボード（第98回 9／7）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
オーストラリアのインフルエンザ動向
•
•
•
•
•
https://www1.health.gov.au/internet/main/publishing.nsf/
Content/cda-surveil-ozflu-flucurr.htm#current
A decrease in influenza-like-illness (ILI) activity in the community has been noted since July 2022. The weekly number of
notifications of laboratory-confirmed influenza in 2022 has decreased to below the weekly 5-year average since mid-July.
Of the 217,898 notifications of laboratory-confirmed influenza, 288 influenza-associated deaths have been notified.
Since commencement of seasonal surveillance in April 2022, there have been 1,708 hospital admissions due to influenza reported
across sentinel hospitals sites, of which 6.5% were admitted directly to ICU.
82.1% of notifications of laboratory-confirmed influenza reported to the NNDSS were influenza A, of which 94.5% were influenza
A(unsubtyped), 0.8% were influenza A(H1N1), and 4.7% were influenza A(H3N2). Influenza B accounted for 0.1% of notifications,
less than 0.1% were A&B co-infections, and 17.7% were untyped.
Of the 2,185 samples referred to the WHOCC to date, 97.4% of influenza A(H1N1), 93.9% of influenza A(H3N2), and the 4
influenza B/Victoria samples, were characterised as antigenically similar to the corresponding
124
vaccine components.
•
•
•
•
•
https://www1.health.gov.au/internet/main/publishing.nsf/
Content/cda-surveil-ozflu-flucurr.htm#current
A decrease in influenza-like-illness (ILI) activity in the community has been noted since July 2022. The weekly number of
notifications of laboratory-confirmed influenza in 2022 has decreased to below the weekly 5-year average since mid-July.
Of the 217,898 notifications of laboratory-confirmed influenza, 288 influenza-associated deaths have been notified.
Since commencement of seasonal surveillance in April 2022, there have been 1,708 hospital admissions due to influenza reported
across sentinel hospitals sites, of which 6.5% were admitted directly to ICU.
82.1% of notifications of laboratory-confirmed influenza reported to the NNDSS were influenza A, of which 94.5% were influenza
A(unsubtyped), 0.8% were influenza A(H1N1), and 4.7% were influenza A(H3N2). Influenza B accounted for 0.1% of notifications,
less than 0.1% were A&B co-infections, and 17.7% were untyped.
Of the 2,185 samples referred to the WHOCC to date, 97.4% of influenza A(H1N1), 93.9% of influenza A(H3N2), and the 4
influenza B/Victoria samples, were characterised as antigenically similar to the corresponding
124
vaccine components.